摘要: Heart failure (HF) is an endemic health problem of great magnitude in the world. In spite considerable clinical and research effort during last decade development new drugs surgical modalities therapy, mortality morbidity remain very high. Accordingly, breakthroughs treatment HF are needed. Late-breaking molecular genetic technology has just begun to be applied studies with identification a number genes involved its pathogenesis prognosticator. Since publication human genome, many changes field have occurred providing investigators remarkable array potential therapeutic tested vivo animal models. this chapter, besides genetics, we discuss current future technologies like proteomics, biomarkers, systems biology, bionics, mitochondrial medicine. addition, approaches developing methodologies that might advance diagnosis therapy analyzed.
springer.com
sci-hub.st 参考文章(123)
Kieran Clarke, Richard Vaughan-Jones, Denis Noble, Frederick Ch’en, Modeling of internal pH, ion concentration, and bioenergetic changes during myocardial ischemia. Advances in Experimental Medicine and Biology. ,vol. 430, pp. 281- 290 ,(1997) , 10.1007/978-1-4615-5959-7_24
James B. Bassingthwaighte, Hong Qian, Zheng Li, The Cardiome Project Advances in Experimental Medicine and Biology. ,vol. 471, pp. 541- 553 ,(1999) , 10.1007/978-1-4615-4717-4_64
Eileen Ingham, John Fisher, Helen E Wilcox, Richard L Knight, Catherine Booth, Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. Journal of Heart Valve Disease. ,vol. 14, pp. 806- ,(2005)
Kartik Mani, Richard N Kitsis, Myocyte apoptosis: programming ventricular remodeling. Journal of the American College of Cardiology. ,vol. 41, pp. 761- 764 ,(2003) , 10.1016/S0735-1097(02)02958-3
Pinak B. Shah, Douglas W. Losordo, Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Advances in Genetics. ,vol. 54, pp. 339- 361 ,(2005) , 10.1016/S0065-2660(05)54014-8
Volkmar Weissig, Jürgen Lasch, Gregory Erdos, Helmut W. Meyer, Thomas C. Rowe, Jeffrey Hughes, DQAsomes: a novel potential drug and gene delivery system made from Dequalinium. Pharmaceutical Research. ,vol. 15, pp. 334- 337 ,(1998) , 10.1023/A:1011991307631
Paolo Madeddu, Therapeutic Angiogenesis and Vasculogenesis for Tissue Regeneration Experimental Physiology. ,vol. 90, pp. 315- 326 ,(2005) , 10.1113/EXPPHYSIOL.2004.028571
Leigh Anderson, Candidate-based proteomics in the search for biomarkers of cardiovascular disease The Journal of Physiology. ,vol. 563, pp. 23- 60 ,(2005) , 10.1113/JPHYSIOL.2004.080473
Robert W. Taylor, Patrick F. Chinnery, Douglass M. Turnbull, Robert N. Lightowlers, Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids Nature Genetics. ,vol. 15, pp. 212- 215 ,(1997) , 10.1038/NG0297-212
Anne L. Taylor, The African American Heart Failure Trial: A Clinical Trial Update American Journal of Cardiology. ,vol. 96, pp. 44- 48 ,(2005) , 10.1016/J.AMJCARD.2005.07.033